IL10 and neoplasm: On the other hand, M2 macrophages arise in response to cytokines such as interleukin (IL)-4, IL-10, IL-13, and transforming growth factor-β (TGF-β), thereby restraining antitumor immunity, promoting tumor-associated vasculature formation, and advancing disease progression (24, 25).